Abstract: Global Direct-to-Consumer (DTC) Genetic Testing Market to Reach US$1. 9 Billion by the Year 2026 . Genomic testing is a revolutionary tool and offers a broad range of applications such as diagnosis of infectious diseases, treatment selection for cancer patients, non-invasive prenatal testing, among others.
New York, Jan. 14, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Direct-to-Consumer (DTC) Genetic Testing Industry" - https://www.reportlinker.com/p05442614/?utm_source=GNW Growth in the global is being driven by new technological advances and rising prevalence of many genetic disorders such as diabetes, cancer, cystic fibrosis, and Alzheimer`s disease globally. Factors such as real time drug discovery, cutting-edge diagnostic methods, and advanced treatments will propel market growth. Increasing user awareness, disposable income, and healthcare expenditure combined with rising adoption of customized medicine to treat genetic disease are other factors driving growth in the market. Public awareness regarding the availability of DTC genetic testing in developing as well as developed countries is continually rising. Leading market players like Ancestry and 23andMe are focusing on offering high-quality DTC genetic testing solutions that ensure accurate and effective test results. Growing awareness among Europeans and Americans regarding racial testing is also driving market demand. Another key driver in the DTC genetic testing market includes elderly consumers who take a keen interest in their healthcare, which is intensified by access to genetic test kits that can detect genes whose variations are associated with an increased risk of developing an age-related disease such as Alzheimer`s.
Amid the COVID-19 crisis, the global market for Direct-to-Consumer (DTC) Genetic Testing estimated at US$971.7 Million in the year 2020, is projected to reach a revised size of US$1.9 Billion by 2026, growing at a CAGR of 12.3% over the analysis period. Ancestry & Relationship Testing, one of the segments analyzed in the report, is projected to grow at a 9.8% CAGR to reach US$915.4 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Nutrigenomics Testing segment is readjusted to a revised 13.6% CAGR for the next 7-year period. This segment currently accounts for a 21% share of the global Direct-to-Consumer (DTC) Genetic Testing market. Ancestry & relationship testing is the most prevalent test type, and the segment is slated to benefit from recent advances that are likely to link ancestry testing with health-related genetic testing. Nutrigenomics testing is used by healthcare professionals to suggest personalized diet and nutritional guidance to overweight people to maintain a healthy lifestyle and manage weight. The segment`s growth is propelled by rising prevalence of obesity and increasing R&D related to nutritional aspects.
The U.S. Market is Estimated at $440.2 Million in 2021, While China is Forecast to Reach $149.8 Million by 2026
The Direct-to-Consumer (DTC) Genetic Testing market in the U.S. is estimated at US$440.2 Million in the year 2021. The country currently accounts for a 43% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$149.8 Million in the year 2026 trailing a CAGR of 15.2% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.3% and 13.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR while Rest of European market (as defined in the study) will reach US$170.8 Million by the end of the analysis period. The US dominates market growth due to the increased awareness about genetic diseases among general populace, growing tendency among general public to identify early and either prevent or provide management of various chronic diseases as well as technical and scientific advancements made in the field of medicine and science in general. Additionally, the regulatory mechanism in the US is relatively better streamlined compared to other markets. Europe represents the next leading market for DTC genetic testing. The market is fueled by increasing healthcare spending by various governments to ensure easy access to advanced genetic tests.
Predictive Testing Segment to Reach $373.2 Million by 2026
The predictive testing market is recording strong growth, driven by exponential growth in the number of diseases and medical conditions that are identifiable through genetic modalities, surging from a mere 90-100 diseases in the early 1990s, to about 1,800 to 2,000 conditions in the present day. In the global Predictive Testing segment, USA, Canada, Japan, China and Europe will drive the 16.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$134.3 Million in the year 2020 will reach a projected size of US$371 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$20.3 Million by the year 2026.
Select Competitors (Total 81 Featured)
Story continues
23andMe, Inc.
Ancestry.com, LLC
Any Lab Test Now
Color Health, Inc.
Direct Laboratory Services, LLC
DNA Diagnostics Center
Easy DNA
Full Genomes Corporation, Inc.
Gene by Gene, Ltd.
Genesis Healthcare
Helix OpCo LLC
Laboratory Corporation of America Holdings
Living DNA
Mapmygenome India Limited
MyHeritage
OmeCare
Positive Bioscience, Inc.
Quest Diagnostics, Inc.
Request A Test, Ltd.
Sonora Quest Laboratories LLC
Xcode Life Sciences
Read the full report: https://www.reportlinker.com/p05442614/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW A Prelude to Genetic Testing Top Ten Genetic Diseases Worldwide Different Types of Genetic Tests include List of Genetic Disorders by Event, Genetic Manifestation and Prevalence A Prelude to Direct-to-Consumer (DTC) Genetic Testing Pros and Cons of Direct-to-Consumer (DTC) Genetic Testing Health Information provided by DTC genetic Tests DTC Genetic Tests? Limitations Market Segments Ancestry Tests Predictive Tests Carrier Tests Nutrigenomics Tests Impact of Covid-19 on Market Prospects of DTC Genetic Testing Market Prospects and Outlook US and Europe Dominate the Global DTC Genetic Tests Market Ancestry Testing Holds Major Share, Predictive Testing Witnesses Rapid Growth Competitive Scenario Recent Market Activity Changing Landscape of DTC Genetic Testing Regulations to Determine Market Viability Regulating DTC Genomic Testing in the UK Data Privacy Concerns to Challenge Market Prospects
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS Consumers Self-Managing Treatments: The New Trend Driving the DTC Genetic Testing Market DTC Genetic Testing Players Join War against COVID-19 DTC Genetic Tests for Cancer Susceptibility EXHIBIT 1: Worldwide Breast Cancer Incidence and Mortality Rates by Region: 2018 Advances in Genome Sequencing Next-Generation Sequencing (NGS) Aids DTC Genetic Testing Market DTC Genetic Testing Presents Lucrative Personalization Opportunities Growing Focus on Service Personalization Generates Opportunities for DTC Genetic Tests Immense Popularity of Ancestry Testing Emergence of DNA-based Nutrition Plans Put the Spotlight on DTC Nutrigenetics Testing Biomarker Discovery Leads to Advanced Genetic Testing Select List of Available Tumor Markers Hybrid Approach of Genetic Testing to Bridge Gap Between Traditional and DTC Models Oncology - A Key Focus Area for Genetic Testing EXHIBIT 2: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040 Ageing Demographics to Drive Demand for Genetic Testing EXHIBIT 3: Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030 Increased Demand for Online Sales of DTC Genetic Tests Use of Artificial Intelligence Adds Value to DTC Genetic Testing Market
4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Direct-to-Consumer (DTC) Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Direct-to-Consumer (DTC) Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 3: World 12-Year Perspective for Direct-to-Consumer (DTC) Genetic Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2021 & 2027
Table 4: World Current & Future Analysis for Ancestry & Relationship Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 5: World Historic Review for Ancestry & Relationship Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 6: World 12-Year Perspective for Ancestry & Relationship Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
Table 7: World Current & Future Analysis for Nutrigenomics Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 8: World Historic Review for Nutrigenomics Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 9: World 12-Year Perspective for Nutrigenomics Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
Table 10: World Current & Future Analysis for Predictive Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 11: World Historic Review for Predictive Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 12: World 12-Year Perspective for Predictive Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
Table 13: World Current & Future Analysis for Carrier Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Carrier Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 15: World 12-Year Perspective for Carrier Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
Table 16: World Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 17: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 18: World 12-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
Table 19: World Current & Future Analysis for Single Nucleotide Polymorphism (SNP) Chips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 20: World Historic Review for Single Nucleotide Polymorphism (SNP) Chips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 21: World 12-Year Perspective for Single Nucleotide Polymorphism (SNP) Chips by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
Table 22: World Current & Future Analysis for Targeted Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 23: World Historic Review for Targeted Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 24: World 12-Year Perspective for Targeted Analysis by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
Table 25: World Current & Future Analysis for Whole Genome Sequencing (WGS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 26: World Historic Review for Whole Genome Sequencing (WGS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 27: World 12-Year Perspective for Whole Genome Sequencing (WGS) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
Table 28: World Current & Future Analysis for Online by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 29: World Historic Review for Online by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 30: World 12-Year Perspective for Online by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
Table 31: World Current & Future Analysis for Over-the-Counter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 32: World Historic Review for Over-the-Counter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 33: World 12-Year Perspective for Over-the-Counter by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES Market Facts Paradigm Shift amongst Consumers Spurring DTC Genetic Testing Market List of Direct-To-Consumer Genetic Tests with FDA Marketing Authorization California to Propose Stringent Legislation for DTC Genetic Testing Providers DTC Genetic Testing - A Highly Competitive Market Regulatory Scenario in US DTC Genetic Testing Market Timeline of Major Events in the US Consumer Genomics Regulations Regulatory Authorities Involved in Regulating DTC Genetics Testing Market Food and Drug Administration A Brief Glance on FDA Controls on DTC Genetic Testing Federal Trade Commission Centers for Medicare and Medicaid Services Patent and Trademark Office The Genetic Information Nondiscrimination Act (GINA) Market Analytics Table 34: USA Current & Future Analysis for Direct-to-Consumer (DTC) Genetic Testing by Test Type - Ancestry & Relationship Testing, Nutrigenomics Testing, Predictive Testing, Carrier Testing and Other Test Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 35: USA Historic Review for Direct-to-Consumer (DTC) Genetic Testing by Test Type - Ancestry & Relationship Testing, Nutrigenomics Testing, Predictive Testing, Carrier Testing and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 36: USA 12-Year Perspective for Direct-to-Consumer (DTC) Genetic Testing by Test Type - Percentage Breakdown of Value Revenues for Ancestry & Relationship Testing, Nutrigenomics Testing, Predictive Testing, Carrier Testing and Other Test Types for the Years 2015, 2021 & 2027
Table 37: USA Current & Future Analysis for Direct-to-Consumer (DTC) Genetic Testing by Technology - Single Nucleotide Polymorphism (SNP) Chips, Targeted Analysis and Whole Genome Sequencing (WGS) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 38: USA Historic Review for Direct-to-Consumer (DTC) Genetic Testing by Technology - Single Nucleotide Polymorphism (SNP) Chips, Targeted Analysis and Whole Genome Sequencing (WGS) Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 39: USA 12-Year Perspective for Direct-to-Consumer (DTC) Genetic Testing by Technology - Percentage Breakdown of Value Revenues for Single Nucleotide Polymorphism (SNP) Chips, Targeted Analysis and Whole Genome Sequencing (WGS) for the Years 2015, 2021 & 2027
Table 40: USA Current & Future Analysis for Direct-to-Consumer (DTC) Genetic Testing by Distribution Channel - Online and Over-the-Counter - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 41: USA Historic Review for Direct-to-Consumer (DTC) Genetic Testing by Distribution Channel - Online and Over-the-Counter Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 42: USA 12-Year Perspective for Direct-to-Consumer (DTC) Genetic Testing by Distribution Channel - Percentage Breakdown of Value Revenues for Online and Over-the-Counter for the Years 2015, 2021 & 2027
CANADA Table 43: Canada Current & Future Analysis for Direct-to-Consumer (DTC) Genetic Testing by Test Type - Ancestry & Relationship Testing, Nutrigenomics Testing, Predictive Testing, Carrier Testing and Other Test Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 44: Canada Historic Review for Direct-to-Consumer (DTC) Genetic Testing by Test Type - Ancestry & Relationship Testing, Nutrigenomics Testing, Predictive Testing, Carrier Testing and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 45: Canada 12-Year Perspective for Direct-to-Consumer (DTC) Genetic Testing by Test Type - Percentage Breakdown of Value Revenues for Ancestry & Relationship Testing, Nutrigenomics Testing, Predictive Testing, Carrier Testing and Other Test Types for the Years 2015, 2021 & 2027
Table 46: Canada Current & Future Analysis for Direct-to-Consumer (DTC) Genetic Testing by Technology - Single Nucleotide Polymorphism (SNP) Chips, Targeted Analysis and Whole Genome Sequencing (WGS) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 47: Canada Historic Review for Direct-to-Consumer (DTC) Genetic Testing by Technology - Single Nucleotide Polymorphism (SNP) Chips, Targeted Analysis and Whole Genome Sequencing (WGS) Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 48: Canada 12-Year Perspective for Direct-to-Consumer (DTC) Genetic Testing by Technology - Percentage Breakdown of Value Revenues for Single Nucleotide Polymorphism (SNP) Chips, Targeted Analysis and Whole Genome Sequencing (WGS) for the Years 2015, 2021 & 2027
Table 49: Canada Current & Future Analysis for Direct-to-Consumer (DTC) Genetic Testing by Distribution Channel - Online and Over-the-Counter - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 50: Canada Historic Review for Direct-to-Consumer (DTC) Genetic Testing by Distribution Channel - Online and Over-the-Counter Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 51: Canada 12-Year Perspective for Direct-to-Consumer (DTC) Genetic Testing by Distribution Channel - Percentage Breakdown of Value Revenues for Online and Over-the-Counter for the Years 2015, 2021 & 2027
JAPAN Table 52: Japan Current & Future Analysis for Direct-to-Consumer (DTC) Genetic Testing by Test Type - Ancestry & Relationship Testing, Nutrigenomics Testing, Predictive Testing, Carrier Testing and Other Test Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 53: Japan Historic Review for Direct-to-Consumer (DTC) Genetic Testing by Test Type - Ancestry & Relationship Testing, Nutrigenomics Testing, Predictive Testing, Carrier Testing and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 54: Japan 12-Year Perspective for Direct-to-Consumer (DTC) Genetic Testing by Test Type - Percentage Breakdown of Value Revenues for Ancestry & Relationship Testing, Nutrigenomics Testing, Predictive Testing, Carrier Testing and Other Test Types for the Years 2015, 2021 & 2027
Table 55: Japan Current & Future Analysis for Direct-to-Consumer (DTC) Genetic Testing by Technology - Single Nucleotide Polymorphism (SNP) Chips, Targeted Analysis and Whole Genome Sequencing (WGS) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 56: Japan Historic Review for Direct-to-Consumer (DTC) Genetic Testing by Technology - Single Nucleotide Polymorphism (SNP) Chips, Targeted Analysis and Whole Genome Sequencing (WGS) Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 57: Japan 12-Year Perspective for Direct-to-Consumer (DTC) Genetic Testing by Technology - Percentage Breakdown of Value Revenues for Single Nucleotide Polymorphism (SNP) Chips, Targeted Analysis and Whole Genome Sequencing (WGS) for the Years 2015, 2021 & 2027
Table 58: Japan Current & Future Analysis for Direct-to-Consumer (DTC) Genetic Testing by Distribution Channel - Online and Over-the-Counter - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 59: Japan Historic Review for Direct-to-Consumer (DTC) Genetic Testing by Distribution Channel - Online and Over-the-Counter Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 60: Japan 12-Year Perspective for Direct-to-Consumer (DTC) Genetic Testing by Distribution Channel - Percentage Breakdown of Value Revenues for Online and Over-the-Counter for the Years 2015, 2021 & 2027
CHINA Table 61: China Current & Future Analysis for Direct-to-Consumer (DTC) Genetic Testing by Test Type - Ancestry & Relationship Testing, Nutrigenomics Testing, Predictive Testing, Carrier Testing and Other Test Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 62: China Historic Review for Direct-to-Consumer (DTC) Genetic Testing by Test Type - Ancestry & Relationship Testing, Nutrigenomics Testing, Predictive Testing, Carrier Testing and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR
Table 63: China 12-Year Perspective for Direct-to-Consumer (DTC) Genetic Testing by Test Type - Percentage Breakdown of Value Revenues for Ancestry & Relationship Testing, Nutrigenomics Testing, Predictive Testing, Carrier Testing and Other Test Types for the Years 2015, 2021 & 2027
Recommendation and review posted by G. Smith
